- Home
- RMR vs VNDA Comparison
RMR vs VNDA Comparison
Compare RMR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- VNDA
- Stock Information
- Founded
- RMR 1986
- VNDA 2002
- Country
- RMR United States
- VNDA United States
- Employees
- RMR N/A
- VNDA N/A
- Industry
- RMR Professional Services
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- RMR Consumer Discretionary
- VNDA Health Care
- Exchange
- RMR Nasdaq
- VNDA Nasdaq
- Market Cap
- RMR 244.2M
- VNDA 237.9M
- IPO Year
- RMR N/A
- VNDA 2006
- Fundamental
- Price
- RMR $15.54
- VNDA $4.38
- Analyst Decision
- RMR
- VNDA Strong Buy
- Analyst Count
- RMR 0
- VNDA 3
- Target Price
- RMR N/A
- VNDA $15.33
- AVG Volume (30 Days)
- RMR 135.1K
- VNDA 506.3K
- Earning Date
- RMR 05-06-2025
- VNDA 05-07-2025
- Dividend Yield
- RMR 11.62%
- VNDA N/A
- EPS Growth
- RMR N/A
- VNDA N/A
- EPS
- RMR 1.06
- VNDA N/A
- Revenue
- RMR $197,672,000.00
- VNDA $201,351,000.00
- Revenue This Year
- RMR $323.25
- VNDA $16.86
- Revenue Next Year
- RMR $1.07
- VNDA $39.78
- P/E Ratio
- RMR $14.57
- VNDA N/A
- Revenue Growth
- RMR N/A
- VNDA 13.37
- 52 Week Low
- RMR $13.48
- VNDA $3.81
- 52 Week High
- RMR $26.43
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- RMR 59.18
- VNDA 53.48
- Support Level
- RMR $14.91
- VNDA $4.17
- Resistance Level
- RMR $15.53
- VNDA $4.42
- Average True Range (ATR)
- RMR 0.38
- VNDA 0.16
- MACD
- RMR 0.12
- VNDA 0.03
- Stochastic Oscillator
- RMR 98.46
- VNDA 79.17
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.